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Lead acetateAbstract Lead intoxication has been a major health hazard in humans. It affects people at all ages.
Its toxicity is associated with various organs of the body and affects different metabolic pathways.
Based on histological data, L-carnitine reduced the severity of tissue damage produced as a result of
exposure of rats to lead acetate. The main objective of this study was to evaluate the underlying
mechanism of protection offered by L-carnitine against lead acetate intoxication using male
Sprague–Dawley rats.
Forty male Sprague–Dawley rats were randomly divided into four groups with ten rats in each.
The first group (G1) served as the control group and animals received standard diet only. The sec-
ond group (G2) received lead acetate in their diet. The third group (G3) was the L-carnitine treated
group and received the normal standard diet supplemented with L-carnitine. While the fourth group
(G4) had a diet supplemented with both lead acetate and L-carnitine. At the end of each experiment,
blood (serum and whole blood) were collected from each animal and analyzed for the following
parameters: serum testosterone levels, serum nitric oxide and serum malondialdehyde. This is in
addition to looking at the enzymatic activities of two important enzymes (superoxide dismutasebia and
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Biological Sciences (2016), http://dx.doi.org/and catalase) and on (glutathione reductase) which are indicative of the antioxidant activities in the
whole blood. The results indicated that L-carnitine will counteract the undesirable effects of lead
intoxication. It exerted its antioxidant potential by reducing the production of ROS and scavenging
free radicals by maintaining and protecting the level of the of antioxidant enzymes SOD, CAT and
glutathione peroxidase.
Conclusion:L-Carnitine may play an important role in reversing the undesirable effects of lead
intoxication. Future studies should be conducted to see whether such an effect is applicable in
humans exposed to lead poising.
 2016 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Lead toxicity has been recognized as a major environmental
health hazard worldwide affecting both humans and animals
at all ages especially young children in humans for a long time
(Lalith Kumar and Muralidhara, 2014). Lead does not have
any beneficial effects to humans, and its presence at high con-
centrations produce very undesirable toxic consequences to
humans affecting all the body organs (Ibrahim et al., 2012;
Markowitz, 2011; Mcguigan, 2012). The proposed mechanisms
for lead toxicity involve fundamental biochemical processes
including its ability to inhibit metabolic activities, mimic the
action of calcium (which can affect calcium-dependent pro-
cesses in the body) and interact with proteins (including those
with sulfhydryl, amine, phosphate, and carboxyl groups
(ASTDR, 2007).
Lead toxicity results in reducing the levels of antioxidants
in the blood as well certain enzymes like catalase and superox-
ide dismutase (Bennet et al., 2007; Singh et al., 2013). It also
decreases the blood concentration of nitric oxide due to its
interference with calcium dependent enzyme like the nitric
oxide synthase and thus causes hypertension in animal models
(Nava-Ruiz et al., 2012; Vaziri, 2008). Lead toxicity results in
an elevation in malondialdehyde (MDA) levels (Dogru et al.,
2007; Sharma et al., 2014). The catalase and superoxide dismu-
tase (SOD) activities and MDA levels were significantly higher
in animals drinking water contaminated with lead acetate as
compared to the control (Soltaninejad et al., 2003). Plasma
luteinizing hormone and follicle stimulating hormone concen-
trations were lower in rats exposed to lead resulting in a con-
siderable decline in fertility status among those rats (Batra
et al., 2004; Mendiola et al., 2011). Lead toxicity induced a sig-
nificant decrease in plasma sex steroid testosterone in males
and 17 beta-estradiol in animals (Ronis et al., 1998; Pillai
et al., 2010). The effects of lead on the biosynthesis of steroid
hormones by Leydig cells in rats were studied and the testos-
terone production was dropped by Leydig cells in rats exposed
to lead (Huang et al., 2002).
Levo-carnitine (L-carnitine) is water soluble antioxidant
located on the mitochondrial membrane and is found in all
mammals (Brass, 2000; Dunning and Robker, 2012).
L-Carnitine is derived from different types of foods (75%)
and is synthesized by the body using various essential amino
acids (25%) like Lysine and Methionine (_Izgu¨t-Uysal et al.,
2001). L-carnitine has very negligible health effects (Liu
et al., 2015), and posses high antioxidant properties. As such,
it is used in the prevention and treatment of oxidative stress
and related health problems (Xiang et al., 2013; Ahmed, E.-S. et al., Ameliorative eﬀects of L-ca
10.1016/j.sjbs.2016.08.010et al., 2014). It helps in facilitating the transport of long chain
fatty acids, through the mitochondrial membrane, used for the
production of energy. It exerts its antioxidant potential by
reducing the production of reactive oxygen species (ROS)
and scavenging free radicals (_Izgu¨t-Uysal et al., 2003; Li
et al., 2012) by maintaining and protecting the level of the of
antioxidant enzymes (SOD, CAT and glutathione peroxidase)
(Go´mez-Amores et al., 2007).
Histological data were obtained from a study on the protec-
tive effects of L-carnitine in Female Wistar-albino rats exposed
to lead acetate (PbAc). It was found that animals exposed to
PbAc caused a significant decrease in HB, HCT and RBC, a
significant increase in WBC, AST, ALT and creatinine as com-
pared to controls. The administration of L-carnitine did not
reverse the effects on HB and HCT levels, while it corrected
the decrease in RBC and the increase in WBC, AST, ALT
and creatinine. These data showed that L-carnitine may reduce
the severity of tissue damage caused by PbAc (Ozsoy et al.,
2011).
The main objective of this study was to evaluate the under-
lying mechanism of the ameliorative effects of L-carnitine,
using male Sprague–Dawley rats exposed to lead acetate.
2. Materials and methods
2.1. Experimental design
Animals: 12–16 weeks old 40 male Sprague–Dawley rats with
an average body weight 140–190 g were used. Rats were
obtained from laboratory animal research center, Faculty of
veterinary medicine, Mansoura University, Mansoura, Egypt.
Animals were housed in separate metal cages. The animals
were left for 14 days for acclimatization before the beginning
of the experiment. Clean drinking water was provided
ad-libitum. Rats were kept at constant environmental and
nutritional conditions (12-h light: 12-h dark and 23+ 2 C,
60–65% humidity) for the duration of the experiment.
2.2. Compounds used
Lead acetate was obtained from El-Naser company, Egypt.
L-carnitine was obtained from Mepaco company, Cairo,
Egypt. Diet: The rats were put on a diet containing nutrients
at these concentrations: protein (150 g/kg), Fat (50 g/kg) with
a total caloric value of 3800–4100Kcal/kg.
The first group (G1) served as the control group and
animals received standard diet only. The second group (2)
received lead acetate in their diet at a concentration of 24 mgrnitine on rats raised on a diet supplemented with lead acetate. Saudi Journal of
Table 1 Effect of L-carnitine on serum MDA level in rats
exposed to lead acetate toxicity (lmol/L).
Groups Range Mean ± SEM
Minimum Maximum
Group1 0.159 0.162 0.1601 ± 0.0002333ª
Group2 0.16 0.21 0.2 ± 0.00666b
Group3 0.01 0.041 0.0284 ± 0.00403c
Group4 0.169 0.183 0.1746 ± 0.00174d
Means with the same letter in each column are not significantly
differed (P> 0.05).
Means with different letter in each column are significantly differed
(P 6 0.05).
SEM= Standard error of mean.
F-value = 368.69.
Ameliorative effects of L-carnitine on rats raised on a diet supplemented with lead acetate 3/kg body weight daily for one month according to Polak et al.
(1996).
The third group (G3) was the L-carnitine treated group and
received the normal diet supplemented with L-carnitine at a
dose of 100 mg/kg body weight daily for one month, While
the fourth group (G4) consumed a diet supplemented with
both lead acetate (dose of 24 mg/kg body weight and an
L-carnitine (dose of 100 mg/kg body weight) daily for one
month (Ozsoy et al., 2011).
Ethical approval: The protocol met the approval of the
Institutional Animal Care and Use Committee at Mansoura
University. The experiments were performed in strict compli-
ance with the ethical guidelines for humane treatment of
animals as set by the Mansoura University guidelines for the
protection of animals used for experimental purposes.
2.3. Collection of blood samples
At the end of each experiment, animals were anesthetized and
then sacrificed by decapitation in a very humane manner.
Blood samples were then collected and divided into two parts:
the first part was dispensed into heparinized tubes to prevent
coagulation and used for the determination of reduced glu-
tathione (GSH) (Beutler et al., 1963), Catalase activity
(Fossati et al., 1980), and superoxide dismutase (SOD) activity
(Nishikimi et al., 1972). The second part of blood sample was
collected in sterile vial and centrifuged at 3000 rpm for 10 min
for collection serum used for biochemical analysis of serum
levels of Malondialdehyde (MDA) (Ohkawa et al., 1979),
serum nitric oxide (NO) (Montogommery and Dymock,
1961) and serum testosterone level (Bayer, 1968).
2.4. Statistical analysis
The mean values and standard errors were calculated for the
obtained data, and the significances for all means have been
carried out by applying F-test using SPSS computer program.
The values have been calculated according to Snedecor and
Cochran (1989).Table 2 Effect of L-carnitine on serum nitric oxide level in rats
exposed to lead acetate toxicity (lmol/L).
Groups Range Mean ± SEM
Minimum Maximum
Group1 0.41 0.479 0.4472 ± 0.00849ª
Group2 0.045 0.08 0.0588 ± 0.00444b
Group3 0.11 0.114 0.1104 ± 0.0004c
Group4 0.025 0.065 0.0464 ± 0.00535db
Means with the same letter in each column are not significantly
differed (P> 0.05).
Means with different letter in each column are significantly differed
(P 6 0.05).
SEM= Standard error of mean.
F-value = 1192.71.3. Results
3.1. Serum malondialdehyde (MDA) level
The mean value of MDA content in serum in-group (2) was
(0.2 ± 0.01 lmol/L) which was higher than that of the control
group (0.1601 ± 0.00023 lmol/L). The mean value of MDA
content in serum in group (3) was (0.284 ± 0.00403 lmol/L)
is lower than that of normal control animal (0.1601
± 0.00023 lmol/L). The mean concentration of MDA content
in serum in group (4) was (0.1746 ± 0.00174 lmol/L and was
lower (p 6 0.05) than that of group (2) as shown in Table 1.
3.2. Serum nitric oxide (NO) level
The mean value of NO content in serum in-group (2) was
(0.0588 ± 0.00444 lmol/L) which was lower than that of con-
trol group (0.4472 ± 0.00849 lmol/L). The mean value of NO
content in serum in group (3) was (0.1104 ± 0.0004 lmol/L)Please cite this article in press as: El-Sherbini, E.-S. et al., Ameliorative eﬀects of L-ca
Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.08.010and is lower than that of normal control animal (0.4472
± 0.00849 lmol/L) as shown in Table 2. In group (4), the
mean value for NO was (0.0464 ± 0.00535 lmol/L) and was
lower than that of control as shown in Table 2.
3.3. Whole blood reduced glutathione (GSH)
The mean value of whole blood GSH content in group (2) was
(0.3219 ± 0.00606 lmol/L) which was lower than that of nor-
mal control group (0.5275 ± 0.00357 lmol/L). The mean
value of whole blood GSH content in group (3) was (0.3953
± 0.00158 lmol/L) which is lower than that of normal control
rats (0.5275 ± 0.00357 lmol/L) but higher than that of lead
acetate treated rats (0.3219 ± 0.00606 lmol/L). In group (4)
the mean value of whole blood GSH was (0.4366
± 0.00229 lmol/L) which was lower than that of normal con-
trol rats (0.5275 ± 0.00357 lmol/L) but higher than that car-
nitine treated rats (0.3953 ± 0.00158 lmol/L) and lead
acetate treated rats (0.3219 ± 0.00606 lmol/L) as shown in
Table 3.
3.4. Whole blood catalase activity
The mean value of whole blood catalase content in group (2)
was (0.2564 ± 0.0100 lmol/L) which was lower than that of
the control group (0.8138 ± 0.0350 lmol/L). The mean
value of whole blood catalase content in group (3) wasrnitine on rats raised on a diet supplemented with lead acetate. Saudi Journal of
Table 3 Effect of L-carnitine on blood GSH level in rats
exposed to lead acetate toxicity (mg/100 ml).
Groups Range Mean ± SEM
Minimum Maximum
Group1 0.439 0.661 0.5275 ± 0.0357ª
Group2 0.309 0.35 0.3219 ± 0.00606b
Group3 0.389 0.402 0.3953 ± 0.00158c
Group4 0.428 0.45 0.4366 ± 0.00229cd
Means with the same letter in each column are not significantly
differed (P> 0.05).
Means with different letter in each column are significantly differed
(P 6 0.05).
SEM= Standard error of mean.
F-value = 22.19.
Table 5 Effect of L-carnitine on erythrocytes SOD activity in
rats exposed to lead acetate toxicity (lgm/ml).
Groups Range Mean ± SEM
Minimum Maximum
Group1 0.25 0.482 0.3756 ± 0.0211ª
Group2 0.22 0.32 0.2432 ± 0.0107b
Group3 0.32 0.43 0.3105 ± 0.0154c
Group4 0.2 0.32 0.2989 ± 0.0117d
Means with the same letter in each column are not significantly
differed (P> 0.05).
Means with different letter in each column are significantly differed
(P 6 0.05).
SEM= Standard error of mean.
F-value = 12.555.
4 E.-S. El-Sherbini et al.(0.4439 ± 0.00805 lmol/L which was higher than that of
group (2) (0.2564 ± 0.0100 lmol/L) as shown in Table 4. In
group (4) the mean value of whole blood catalase content
was (0.3228 ± 0.0153 lmol/L which is higher than that of
group (2) (0.2564 ± 0.0100 lmol/L) as shown in Table 4.
3.5. Whole blood superoxide dismutase activity (SOD)
In the present study the mean value of whole blood SOD con-
tent in group (2) was (0.2629 ± 0.0174 lmol/L) which was
lower than that of normal control rats (0.3105
± 0.0211 lmol/L). The mean value of whole blood SOD con-
tent in group (3) was (0.3105 ± 0.0154 lmol/L) which was
higher than that of group (2) (0.2432 ± 0.0107 lmol/L) as
shown in Table 5. In group (4) the mean value of whole blood
SOD content was (0.2989 ± 0.0117 lmol/L) which is higher
than that of group (2) (0.2432 ± 0.0107 lmol/L) and signifi-
cantly lower than that of group (3) (0.3105 ± 0.0154 lmol/
L) as shown in Table 5.
3.6. Serum testosterone
The mean value of testosterone levels in serum from group (2)
treated rats was (0.664 ± 0.0397 lmol/L) which was lower
than that of normal control rats (1.562 ± 0.0674 lmol/L).Table 4 Effect of L-carnitine on erythrocytes catalase activity
in rats exposed to lead acetate toxicity (lgm/ml).
Groups Range Mean ± SEM
Minimum Maximum
Group1 0.74 1.02 0.8138 ± 0.0350ª
Group2 0.23 0.312 0.2564 ± 0.0100b
Group3 0.41 0.47 0.4439 ± 0.00805c
Group4 0.237 0.43 0.3228 ± 0.0153d
Means with the same letter in each column are not significantly
differed (P> 0.05).
Means with different letter in each column are significantly differed
(P 6 0.05).
SEM= Standard error of mean.
F-value = 152.115.
Please cite this article in press as: El-Sherbini, E.-S. et al., Ameliorative eﬀects of L-ca
Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.08.010The mean value of testosterone content in serum in group
(3) treated rats was (3.85 ± 0.302 lmol/L) which was higher
than that of normal control rats (1.562 ± 0.0674 lmol/L) as
shown in Table 6. In group (4) the mean value of testosterone
in serum (5.598 ± 0.429 lmol/L) was higher than that of nor-
mal control group (1.562 ± 0.0674 lmol/L) as shown in
Table 6.
4. Discussion
The results are consistent with what has been reported indicat-
ing that dietary supplementation of L-carnitine reduced malon-
dialdehyde levels and provided a protective effect in rats
exposed to lead (Lo¨ster and Bo¨hm, 2001; Geng et al., 2004;
Shokrzadeh et al., 2013). L-Carnitine attenuated free radical
induced oxidative stress under various pathological conditions
(Gu¨lc¸in, 2006). It was hypothesized that L-carnitine may
reduce intermittent hypoxia induced by oxidative stress and,
thereby, improving the skeletal muscle performance, resulting
in delaying muscle fatigue mediated by the reduction of free
radical induced oxidative damage due to the antioxidant and
anti-free radical activity of L-carnitine (Bin and Hussain,
2012).
The results concerning the inhibition of NO production in
rats exposed to low levels of lead have been in concurrenceTable 6 Effect of L-carnitine on serum testosterone level in
rats exposed to lead acetate toxicity (n mol/L).
Groups Range Mean ± SEM
Minimum Maximum
Group1 1.36 1.86 1.562 ± 0.0674ª
Group2 0.55 0.84 0.664 ± 0.0397b
Group3 3 5.47 3.85 ± 0.302c
Group4 3.18 6.52 5.598 ± 0.429d
Means with the same letter in each column are not significantly
differed (P> 0.05).
Means with different letter in each column are significantly differed
(P 6 0.05).
SEM= Standard error of mean.
F-value = 70.72.
rnitine on rats raised on a diet supplemented with lead acetate. Saudi Journal of
Ameliorative effects of L-carnitine on rats raised on a diet supplemented with lead acetate 5with what has been reported earlier which indicated that such
an effect resulted in increases in vascular resistance, decreases
in renal blood flow and glomerular function and an enhance-
ment of oxidative stress. It was suggested that lead-induced
hypertension might be related to a decrease in NO and conse-
quent vasoconstriction, rather than to a decrease in renal
blood flow or to decreases in renal sodium (Dursun et al.,
2005; Sun et al., 2005; Nascimento et al., 2014). It was reported
that nitric oxide synthase activity in the hippocampus, cerebel-
lum and cerebral cortex were inhibited by exposure to low
levels of lead and the level of inhibition was time as well as
concentration dependent (Dong et al., 2003). The data
indicated that the antioxidant activity of L-carnitine and its
derivatives resulted in decreased endothelial NO synthase
(ecNo) gene expression. This corroborates what was reported
by others where a direct stimulatory effect of L-carnitine on
gene and protein expression of oxidative stress related markers
like hemeoxygenase-1 (HO-1) and ecNO was reported.
Hemeoxygenase-1 and ecNO are known antioxidants with
both anti-proliferative and anti-inflammatory potential. Thus,
their increased expression would be expected to provide a pro-
tective effect from oxidative stress related damage (Calo` et al.,
2006; Saeidnia and Abdollahi, 2013). L-carnitine kept NO in a
reduced form which may have therapeutic potential (Dunlap
et al., 2008). It was published that the prolonged critical illness,
maintaining normoglycemia, and not glycemia-independent
action of insulin prevented excessive systemic NO release on
day 3 and appeared to preserve local endothelial function.
Factors contributing to this finding may comprise direct
endothelial damage, direct effects on the enzyme activity,
decreased substrate availability or less NO-induced inhibition
(Ellger et al., 2008).
The data showed that lead resulted in significantly decreas-
ing the levels of reduced glutathione. These findings were in
agreement with published work that showed that lead
significantly decreased reduced glutathione (GSH)/oxidative
glutathione (GSSG) and protein sulfhydryl groups (PSH)/
glutathione–protein mixed disulfide (GSSP) ratio as well
as glutathione reductase activities in a concentration-
dependent manner (Chen et al., 2004; Suresh et al., 2011). It
was reported that lead induced cell death involved in GSH
deprivation with a significant decrease in the level of GSH, a
critical intracellular antioxidant, observed at all the lead con-
centrations. These results suggested that the neurotoxic effect
of lead may be mediated by apoptosis and prostaglandin E2
release, which could be potentially detrimental to neuronal
survival. In another study, it was indicated that a reduction
in the concentration of GSH in liver and kidney tissues after
lead exposure resulted in a decrease in the liver and kidney
concentrations of GSH due to oxidative action caused by lead
(Jurczuk et al., 2006).
Acetyl L-carnitine protected against oxidative stress and
was proposed as a therapeutic agent for several neurodegener-
ative disorders. Accordingly, it was suggested that treatment of
astrocytes by acetyl-L-carnitine which induces hemeoxygenase-
1 resulting in generating the vasoactive molecule carbon
monoxide and the potent antioxidant bilirubin, which may
explain the protective system potentially active against brain
oxidative injury (Cao et al., 2014).
The data indicated that the catalase activity declined after
an initial compensatory rise due to oral exposure of lead. LeadPlease cite this article in press as: El-Sherbini, E.-S. et al., Ameliorative eﬀects of L-ca
Biological Sciences (2016), http://dx.doi.org/10.1016/j.sjbs.2016.08.010reduced the erythrocyte thiol content and antioxidant defense
indicating possible role of free radicals in pathogenesis lead
toxicity (Lo´pez et al., 2007; Kasperczyk et al., 2014).
Published data indicated that the administration of
L-carnitine resulted in elevation of antioxidant enzymes like
catalase, SOD, and GSH (Ucu¨ncu¨ et al., 2006; Hisatomi
et al., 2008). They reported that L-carnitine had an antioxidant
potential, antioxidant defense enzyme in the cauda epididymis
(Izgu¨t-Uysal et al., 2001). In another study, L-carnitine treat-
ment increased catalase activity in both blood and gastric
mucosa due to its ability to scavenge oxygen free radicals in
mammalian tissues (Go´mez-Amores et al., 2006; Li et al.,
2014). Data reported in the literature indicated that propionyl
L-carnitine (PLC) protected cells from toxic oxygen reactive
free radical species and enhanced the catalase activity. The
antioxidant capacity of PLC in spontaneously hypertensive rats
and its beneficial use protecting tissues from hypertension-
accompanying oxidative damage (Go´mez-Amores et al.,
2006). Other studies also reported that the antioxidant proper-
ties of L-carnitine proponyl and L-carnitine on spontaneously
hypertensive animals prevented endothelial dysfunction
through their antioxidant activities (Sleem et al., 2014).
The results indicated that lead resulted in a decrease in
SOD activity, while an increase in this enzyme’s activity was
noted in rats fed with L-carnitine in their diet. It is well known
that SOD represents the first line of defense against oxygen
toxicity. It catalyzes the dismutation of superoxide anion pro-
ducing hydrogen peroxide. These data are consistent with what
has been reported in the literature whereby a significant
decrease in SOD activity was noted in adult rats that received
lead as lead acetate solution and that Lead induced oxidative
stress in a dose dependent manner (Annabi Berrahal et al.,
2007). Other studies confirmed those findings and reported a
significant decrease in the activities of antioxidant enzymes
such as erythrocyte-SOD and erythrocyte-catalase in battery
manufacturing workers of Western Maharashtra (India) who
were occupationally exposed to lead over a long period of time
(Patil et al., 2006). A decrease in erythrocyte-SOD and
erythrocyte-catalase activities had an adverse effect on heme
biosynthesis and imbalance of pro-oxidant resulting in an
increase in lipid peroxidation. L-Carnitine increased SOD
levels and other antioxidant enzymes. These results were sup-
ported by those of others (Tan et al., 2008) who reported that
the change in the antioxidant potential of retinal pigment
epithelium cells was induced by an increase in SOD and
GSH. It was indicated that L-carnitine enhanced T-cell prolif-
erative responses, and may have a vital role in improving func-
tions immune system cells particularly the lymphocytes due to
its antioxidant activities. Also, L-carnitine had a radioprotec-
tive role in addition to its antioxidant abilities (Thangasamy
et al., 2008). Studies on L-carnitine supplementation either
individually or in combination with vitamin E reversed brain
and retinal damage caused by radiation via increasing the
activity of SOD and catalase enzymes in the brain (Sezen
et al., 2008). L-Carnitine and alpha-lipoic acid seemed to have
protective effects against oxidative damage in adjuvant arthri-
tis model (Cabral et al., 2014).
The results indicated that lead acetate reduced the testos-
terone levels, while L-carnitine had an opposite effect. Pub-
lished work on lead showed that it influenced Leydig cellrnitine on rats raised on a diet supplemented with lead acetate. Saudi Journal of
6 E.-S. El-Sherbini et al.steroidogenesis, which resulted in a reduction of testosterone
levels resulting in a low sperm counts in both human beings
and animals. Lead acetate significantly inhibited human chori-
onic gonadotropin (hCG) and dibutyryl cAMP (dbcAMP)
stimulated progesterone production from 20 to 35% in MA-
10 cells (Liu et al., 2003). A study on testosterone levels in
serum of aged rats, showed a significant decrease in those
levels in relation to age (P 6 0.05). However, L-carnitine and
L-arginine reversed this effect and returned testosterone levels
near to the levels of that of the control in the young rats
(Masi et al., 2003; El-Sayed et al., 2005). It was also found that
acetyl L-carnitine protects against the decreases in dopamine
and testosterone that normally occur after exposure to both
acute and chronic stresses and decreases other markers of
stress. These results are supported by Rani and
Panneerselvam (2002) who found that neuro-protective effect
on the brain in old rats was achieved by the elevation of
antioxidants with L-carnitine. L-Carnitine has also antioxidant
properties that protect sperm membranes against toxic reactive
species and may preserve sperm membranes in roosters,
thereby extending the life span of sperm and thus increasing
male fertility (Neuman et al., 2002). It was reported that the
level of free L-carnitine in seminal plasma, significantly corre-
lated with sperm concentration, motility, and viability. As a
result, L-carnitine levels can be taken as a biochemical index
used for guidance for clinical treatment of male infertility as
well as for studying the mechanisms of male reproduction
(Banihani et al., 2014; Manee-In et al., 2014; Pons-Rejraji
et al., 2014).
5. Conclusion
Based on the above, it would be obvious to conclude that L-
carnitine has a protective power to counteract the effect of lead
acetate in rats. Future study should focus on the use of L-
carnitine in workers who are exposed to lead toxicity.References
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